Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession
Gráinne Forrest
• Currently a member of BARQA and the Institute of Clinical Research, Gráinne Forrest will now serve as the head of quality assurance at Clintec's (Glasgow, UK) Glasgow-based headquarters, where she will manage the global quality assurance team and further develop and deliver a quality strategy for the company.
Annette Doherty
• Being recognized for her services to the pharmaceutical industry for the past 20 years, Annette Doherty, PhD, the senior vice president and head of worldwide pharmaceutical sciences for Pfizer (New York, NY) has been made an Officer of the Order of the British Empire in the Queen's Birthday Honors celebrations.
Karen Bateman
• Karen Bateman will bring with her quality assurance background in both pharmaceutical manufacturing and R&D to her new position as head of quality assurance for LCG Bioscience (Cambridgeshire, UK).
Jonathan Andrus
• The Vice President of Clinical Data Management and Regulatory Operations for BioClinica's (Newtown, PA) eClinical Service Division, Jonathan Andrus, has been elected as the Drug Information Association North American Special Interest Area Communities eClinical Chair.
• Bringing with him more than 25 years of experience in the areas of scientific computing, biostatistics, bioinformatics, programming, and global data management, Monte Jarvis will oversee Covance's (Princeton, NJ) data management and biostatistics for Phase IIIb/IV clinical trials, patient registries, and observational studies as he serves as the new vice president of global data management and biostatistics for peri-approval services.
• Previously the senior director in clinical research operations specializing in patient recruitment at Merck & Co. (Whitehouse Station, NJ), Lars-Olof Eriksson, PhD, is now serving as the vice president of Parexel's (Boston) Start-up and Accelerated Recruitment Team (START).
• Being an accomplished senior executive and having developed several life sciences companies throughout his career, Hervé de Kergrohen, MD, will now serve as the new chief executive officer and director of Anavex Life Sciences (Geneva, Switzerland).
• Joining MMG (Rockville, MD) as the new Senior Strategist and Vice President of General Medicine, Nikki Fink will utilize over 10 years of provider and sponsor experience designing and directing patient recruitment programs.
• Now leading the customer delivery group as the Chief Operating Officer, John Jordan will be responsible for global operations within the services branch of CRF Health (Lansdale, PA).
• Upon the opening of a new office in Brussels, Chiltern (London, UK) has appointed Maurizio Passinisi as the new country manager for Belgium and The Netherlands.
• As the new Senior Vice President of Neuropsychiatry to INC Research's (Raleigh, NC) Central Nervous System team, Tom Zoda, PhD, will be responsible for providing senior level oversight of all psychiatry and neurology projects on a global basis.
The Institute of Clinical Research's Education Manager Sue Fitzpatrick shaking the hand of Abdullah Aljoudi, MD, after he completes one of the organization's clinical trial courses recently made available in Saudi Arabia.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.